New Delhi: The government on Friday removed restrictions on exports of formulations made from Paracetamol amid the outbreak of COVID-19.

However, restrictions on exports of Paracetamol active pharmaceutical ingredients (APIs) will continue on, the Directorate General of Foreign Trade (DGFT) said in a notification.

"The formulations made from Paracetamol (including fixed-dose combinations) are made free for export with immediate effect. However, Paracetamol APIs will remain restricted for export," it said.

The government on March 3 had put export restrictions on 26 pharma ingredients and medicines, including paracetamol.

The total number of coronavirus cases in India has gone up to 13,387 while the death toll has risen to 437, according to the latest figures from the Health Ministry. In the past 24 hours, 1,007 fresh COVID-19 infections and 23 deaths were reported.

On the other hand, 1748 patients have been cured of the virus or discharged. Maharashtra is the worst affected state with 3,205 cases and 194 deaths.